Carboxylic acid salts
Selleck Chemical LLC b-Glycerophosphate sodium salt hydrate S3620-500mg
-Glycerophosphate (sodium salt hydrate) is a potent protein phosphatase inhibitor
Selleck Chemical LLC Taurocholic acid sodium salt
Taurocholic acid sodium salt (Sodium Taurocholate TANa) is a sodium salt of taurocholic acid and occurs in the bile of mammals Taurocholic acid is used as a cholagogue and choleretic
Apexbio Technology LLC CX-4945 sodium salt 1309357-15-0 50mg
CX-4945 sodium salt (Silmitasertib sodium salt CAS 1309357-15-0) is a potent and selective inhibitor of casein kinase 2 (CK2) effectively targeting both the CK2 and CK2 catalytic subunits By inhibiting CK2 activity CX-4945 disrupts signaling pathways involved in cell cycle progression transcriptional regulation and cell survival The compound exhibits oral bioavailability and is widely utilized in research focused on tumor biology mechanistic studies of signaling cascades and the functional characterization of protein kinases
Cayman Chemical Fluvastatin sodium salt hydr
An HMG-CoA reductase inhibitor (Ki = 0.3 nM for the rat enzyme); inhibits CYP2C9 (IC50 = 100 nM); inhibits oxidized LDL-induced ferroptosis and reverses oxidized LDL-induced decreases in GPX4 and system Xc- levels in HUVECs; decreases serum cholesterol, triglyceride, and phospholipid levels, the formation of TBARS, and vascular ACE activity in rabbits fed a high-cholesterol diet at 2 mg/kg per day; increases survival in a mouse model of myocardial infarction at 10 mg/kg per day
Medchemexpress LLC Sodium formate | 141-53-7 | MFCD00013101 | 99.0% | 68.01 g/mol | CHNaO2 | 250 G
Sodium formate is the sodium salt of formic acid supplied as a solid biochemical reagent and reducing agent. It has a listed purity of 99.0% and is commonly used in catalytic oxidations and biochemical assays; storage recommendations include sealed storage at 4°C, away from moisture.
- High purity reagent: 99.0% purity suitable for analytical and assay use.
- Solid form: supplied as a dry powder for easy handling and storage.
- Reduces oxidation: provides reducing force in catalytic oxidation reactions.
- Surface chemistry: can react with zinc salts to form zinc oxide layers on supports.
- Multiple pack sizes: available in laboratory pack sizes, including 250 g.
- Stable storage: store sealed at 4°C and protect from moisture; in solvent, -80°C (6 months) or -20°C (1 month) for short-term.
TARGETMOL CHEMICALS INC BAY-299 5MG
Also available in 10 mg 25 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. BAY-299 is an effecitve inhibitor of the bromodomain and PHD finger family member BRPF2 and the TATA box binding protein-associated factors TAF1 and TAF1L with IC50s of 67 nM 8 nM and 106 nM respectively. purity: 97%
Pfanstiehl Inc Sodium Succinate Hexahydrate, High Purity, Low Endotoxin, Low Metals USP-NF, JPE (D-161) 1Kg GMP, Multi-compendial CAS: 6106-21-4 Injectable Excipient Grade
Pfanstiehl Sodium Succinate (Hexahydrate) High Purity, Low Endotoxin, Low Metals is a multi-compendial fully hydrated form of Na succinate that has been specifically designed and formulated to remove impurities such as endotoxin, trace metals, and nitrosamines. Manufactured in the USA under ICH-Q7 cGMP conditions, Pfanstiehl Sodium Succinate meets parenteral (injectable) excipient grade standards, making it ideal for pharmaceutical, biologic, and vaccine bioprocessing and formulation. Pfanstiehl Brand Sodium Succinate (Anhydrous) is compliant with the USP monograph established in 2017 and available as USP-NF (United States Pharmacopoeia National Formulary) and JP (Japanese Pharmacopoeia) Compendial, U.S.P. , cGMP , pharmaceutical grade .
Pfanstiehl Inc Dramamine Active EDGT (D-135) 1kg pack API, active pharmaceutical ingredient- CAS: 523-87-5
Dramamine Active EDGT (D-135) 1kg pack API, active pharmaceutical ingredient- CAS: 523-87-5
Cayman Chemical NADP sodium salt hydrate
The oxidized form of NADPH; serves as a cofactor in various biological reactions
![eMolecules 3-(AMINOMETHYL)-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE 2HCL | 1187930-12-6 | MFCD11506164 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502180333.JPG-250.jpg)
eMolecules 3-(AMINOMETHYL)-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE 2HCL | 1187930-12-6 | MFCD11506164 | 1g
AstaTech | 3-(AMINOMETHYL)-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE 2HCL | 1g | 248480901 | 32441 | 95.000 | 1187930-12-6 | MFCD11506164 | 237.120 | C9H14Cl2N2O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Bay-299 | 2080306-23-4 | MFCD30480933 | >98.0% | 429.47 Da | C25H23N3O4 | 25 MG
BAY-299 is a small-molecule chemical probe that potently inhibits bromodomain-containing proteins BRPF2/BRD1 and the second bromodomain of TAF1/TAF1L. It is for research use only and has been reported with low-nanomolar biochemical potency and cellular activity in published and vendor assays.
- Potent dual bromodomain inhibitor of BRPF2/BRD1 and TAF1.
- Low-nanomolar biochemical potency in reported assays.
- Selective over many other bromodomains, reducing off-target binding.
- Demonstrated cell activity in NanoBRET and related assays.
- Supplied as a high-purity solid suitable for research applications.
- Useful for mechanistic studies of chromatin and transcriptional regulation.
eMolecules Ambeed / Copper(II) 2-ethylhexanoate / 1g / 588343068 / A652646 / / 149-11-1 / MFCD00015695 / 349.958 / C16H30CuO4
Ambeed / Copper(II) 2-ethylhexanoate / 1g / 588343068 / A652646 / / 149-11-1 / MFCD00015695 / 349.958 / C16H30CuO4
Apexbio Technology LLC Cefotaxime (sodium salt)(Synonyms: Claforan, Cefotaxime Sodium, Cefotaxim sodium salt, Cefotaxime Na, Sodium cefotaxime), 5g, CAS: 64485-93-4.
Cefotaxime sodium (CAS 64485-93-4) is a third-generation cephalosporin antibiotic belonging to the -lactam group characterized by inhibition of bacterial cell-wall synthesis through binding to penicillin-binding proteins In vitro analyses show strong inhibitory efficacy against various bacterial species notably cefotaxime exhibits an MIC below 0 1 g/ml against Streptococcus pneumoniae It also demonstrates high activity against Haemophilus influenzae including -lactamase-producing strains In vivo mouse model studies revealed that combination therapy of cefotaxime with minocycline enhanced survival following Vibrio vulnificus infection compared to single-agent treatments Clinically cefotaxime has been evaluated in pneumonia therapy demonstrating good tolerance and therapeutic utility in targeting susceptible bacterial pathogens